Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 2:2
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 4
1 (33.3%)Profiling Urticaria for the Identification of Subtypes
Completed
- Conditions
- Non-autoreactive Chronic Spontaneous UrticariaAutoimmune Chronic Spontaneous UrticariaAutoreactive, Non-autoimmune Chronic Spontaneous Urticaria
- First Posted Date
- 2012-07-10
- Last Posted Date
- 2015-07-28
- Lead Sponsor
- Marcus Maurer
- Target Recruit Count
- 195
- Registration Number
- NCT01637116
- Locations
- 🇩🇪
University of Berlin Charité, Berlin, Germany
Study on Mastocytosis for Rupatadine Treatment
Phase 2
Completed
- Conditions
- Mastocytosis
- Interventions
- Drug: Rupatadin
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2016-11-03
- Lead Sponsor
- Marcus Maurer
- Target Recruit Count
- 30
- Registration Number
- NCT01481909
- Locations
- 🇩🇪
University Charité, Berlin, Germany
Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria
- First Posted Date
- 2011-09-30
- Last Posted Date
- 2011-10-03
- Lead Sponsor
- Marcus Maurer
- Target Recruit Count
- 30
- Registration Number
- NCT01444196
- Locations
- 🇩🇪
Department of Dermatology, Venerology and Allergology, Berlin, Germany
Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2016-12-26
- Lead Sponsor
- Marcus Maurer
- Target Recruit Count
- 76
- Registration Number
- NCT01170949
- Locations
- 🇩🇪
Charité University, Berlin, Germany
News
No news found